Work

Efficacy and safety of pegvorhyaluronidase alfa (PEGPH20; PVHA) and pembrolizumab (pembro) combination therapy in patients (Pts) with stage III/IV non-small cell lung cancer (NSCLC)

Year: 2019

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdz437.032

Authors: J.P. Ward, M. Shum, E. Bertino, V. Lin, V. Kuruvadi, T. Heineman

Institutions: Washington University in St. Louis, Oncology Institute of Hope and Innovation, The Ohio State University, Halozyme Therapeutics (United States)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2990851697

FWCI: 0.105

Cites:

Cited by: 4

Related to: 10